CARLSBAD, Calif., Sept. 25, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it will showcase its product portfolio at the upcoming EuroSpine 2013 meeting, which is being held in Liverpool, UK, from October 2nd to 4th, 2013. Alphatec Spine will be located in booth number A21. The EuroSpine annual meeting is an important venue in Europe for sharing research, knowledge and innovation in the prevention and treatment of spinal disorders.
This year Alphatec Spine will be showcasing key products from all of its major portfolio segments including, MIS, Degenerative, Deformity, Interbody, Cervical and Biologics. Products to be focused on in Alphatec Spine's booth and workshop will include the ILLICO® Multi-Level MIS system, the Alphatec Solus® ALIF cage, the Epicage® MIS interbody device, and the Zodiac® DVR (Direct Vertebral Rotation) Deformity system. Additionally, the Company will also be highlighting several of its and Scient'x S.A.S.'s products that have CE clearance, including the DiscoCerv® artificial disc, the Isobar™ Evolution dynamic rod, the PCB Evolution interbody device and the HeliFix® interspinous process device, among others.
"We are excited to participate in EuroSpine 2013 and to discuss the breadth of our product portfolio, while exchanging ideas and best practices around key spinal topics that affect the lives of the patients we serve," said Les Cross, Chairman and CEO of Alphatec Spine, Inc. "Continuing to grow and support our international business is a key component of our corporate strategy. EuroSpine 2013 provides a forum where we can connect with existing and potential international customers and demonstrate the unique benefits and value of our complementary product suite. We are proud to play a significant role in helping patients around the world regain their active lifestyles."
In addition, on Friday, October 4th at 12:00pm in Room number 4A, Alphatec Spine will be hosting a workshop entitled, "Advanced MIS and Open Techniques in Deformity Correction", featuring presentations and facilitation by key thought leaders in spinal surgery: Dr. Masood Shafafy, QMC Nottingham, UK and Dr. Robert Lee, RNOH Stanmore, UK.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets physician-inspired products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include references to the Company's belief that certain of its products offer competitive functionalities in the marketplace. The words "believe," "will," "should," "expect," "intend," "estimate" and "anticipate," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: Alphatec Spine's ability to continue to grow and support its international business; the uncertainty of success in developing or acquiring and commercializing new products or product technologies; acceptance of Alphatec Spine's and its affiliate's products by the international surgeon community, including without limitation the products discussed in this press release; Alphatec Spine's ability to develop and expand its U.S. and/or global revenues; continuation of favorable third part payor reimbursement for procedures performed using Alphatec Spine's products; unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine's ability to successfully control its costs or achieve profitability; uncertainty of additional funding; Alphatec Spine's ability to compete with other competing products and with emerging new technologies; product liability exposure; patent infringement claims and claims related to Alphatec Spine's intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.